P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.

Han, Yue; Bai, Can; He, Xi-Meng; Ren, Qing-Ling

Han, Yue; Bai, Can; He, Xi-Meng; Ren, Qing-Ling.

Afiliación

Han Y; Department of Gynecology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
Bai C; Acupuncture & Chronobiology Key Laboratory of Sichuan Province, Chengdu University of Traditional Medicine, Chengdu, 610075, China.
He XM; Acupuncture & Chronobiology Key Laboratory of Sichuan Province, Chengdu University of Traditional Medicine, Chengdu, 610075, China.
Ren QL; Department of Gynecology, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China. yfy0047@njucm.edu.cn.

Purinergic Signal ; 19(1): 145-153, 2023 03.

Article en En | MEDLINE | ID: mdl-35235139

Asunto(s)

Receptores Purinérgicos P2X7; Neoplasias del Cuello Uterino; Femenino; Humanos; Proliferación Celular; Células HeLa; Antagonistas del Receptor Purinérgico P2X/farmacología; Antineoplásicos/uso terapéutico

Palabras clave

Atractylenolide I; Hela cells; Human cervical cancer cells; P2X7Rs; SiHa cells

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Cuello Uterino / Receptores Purinérgicos P2X7 Límite: Female / Humans Idioma: En Revista: Purinergic Signal Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google